http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101780075-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6dbbe67f09b7415b0719b95987214c70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate | 2009-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f596cc09b49fdce41f2b7c76a2d6ded9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97af3447ed1f93818b8f385a91f6ae38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ddc0ffcac923041e44446d10e29b939 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47287553583647559200886f48ece521 |
| publicationDate | 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101780075-B |
| titleOfInvention | Combined drug for treating insomnia |
| abstract | The invention provides a use of tizanidine hydrochloride and tandospirone citrate in the preparation of a combined drug for treating insomnia. The weight ratio of a tizanidine hydrochloride derivative to the tandospirone citrate is 1-4 to 5-20. The combined drug has the advantages that: (1) from different mechanisms of action, the combined drug has the function of synergistic effect against insomnia; (2) the clinical dosage of one or two drugs can be reduced to attenuate virulence; and (3) the invention can facilitate patients to carry and take. |
| priorityDate | 2009-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.